PubMed ID: 31708275 Author(s): Guymer RH, Rosenfeld PJ, Curcio CA, Holz FG, Staurenghi G, Freund KB, Schmitz-Valckenberg S, Sparrow J, Spaide RF, Tufail A, Chakravarthy U, Jaffe GJ, Csaky K, Sarraf D, Monés JM, Tadayoni …
WRC
Prevalence and Severity of Artifacts in Optical Coherence Tomographic Angiograms.
PubMed ID: 31804666 Author(s): Holmen IC, Konda SM, Pak JW, McDaniel KW, Blodi B, Stepien KE, Domalpally A. Prevalence and severity of artifacts in optical coherence tomographic angiograms. JAMA Ophthalmol. 2020 Feb 1;138(2):119-126. doi: 10.1001/jamaophthalmol.2019.4971. …
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
PubMed ID: 31395505 Author(s): Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY; Age-Related Eye Disease Study 2 Research Group. Visual acuity outcomes after anti-vascular endothelial growth factor …
A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study.
PubMed ID: 32353052 Author(s): Etheridge T, Dobson ETA, Wiedenmann M, Papudesu C, Scott IU, Ip MS, Eliceiri KW, Blodi BA, Domalpally A. A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular …
Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
PubMed ID: 31558345 Author(s): Domalpally A, Agrón E, Pak JW, Keenan TD, Ferris FL 3rd, Clemons TE, Chew EY. Prevalence, risk, and genetic association of reticular pseudodrusen in age-related macular degeneration: Age-Related Eye Disease Study …
Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.
PubMed ID: 31600368 Author(s): Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Chan CK; SCORE2 Investigator Group. Month 24 outcomes after treatment initiation with anti-vascular endothelial growth factor therapy for macular edema due …
Bilateral Globe Penetration From Electromyography Electrode Placement for Intraoperative Neurophysiologic Monitoring.
PubMed ID: 37008380 Author(s): Bowen RC, Possin ME, Altaweel MM. Bilateral Globe Penetration From Electromyography Electrode Placement for Intraoperative Neurophysiologic Monitoring. J Vitreoretin Dis. 2019 Oct 16;4(2):136-138. doi: 10.1177/2474126419868888. eCollection 2020 Mar-Apr. PMID 37008380 Journal: …
Vascular changes in diabetic retinopathy-a longitudinal study in the Nile rat.
PubMed ID: 31101854 Author(s): Toh H, Smolentsev A, Bozadjian RV, Keeley PW, Lockwood MD, Sadjadi R, Clegg DO, Blodi BA, Coffey PJ, Reese BE, Thomson JA. Vascular changes in diabetic retinopathy-a longitudinal study in the …
LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.
PubMed ID: 29746405 Author(s): Peterson JS, Rockwell K Jr, Scott IU, Ip MS, VanVeldhuisen PC, Blodi BA; SCORE2 Investigator Group. Long-term physical stability, sterility, and anti-VEGF bioactivity of repackaged bevacizumab in 2-ml glass vials. Retina. …